ICD-10 · PDGM grouping
E85 Amyloidosis
All 9 codes in the E85 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
9
Can lead a claim
9
Cannot lead a claim
0
What CMS assigns to E85
All 9 codes group to MMTA - Endocrine. None of the 9 is assigned a comorbidity subgroup. Every code can lead a claim.
Every code in E85
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| E85.0 | Non-neuropathic heredofamilial amyloidosis | Can lead a claim | I | None |
| E85.1 | Neuropathic heredofamilial amyloidosis | Can lead a claim | I | None |
| E85.2 | Heredofamilial amyloidosis, unspecified | Can lead a claim | I | None |
| E85.3 | Secondary systemic amyloidosis | Can lead a claim | I | None |
| E85.4 | Organ-limited amyloidosis | Can lead a claim | I | None |
| E85.8 Other amyloidosis | ||||
| E85.81 | Light chain (AL) amyloidosis | Can lead a claim | I | None |
| E85.82 | Wild-type transthyretin-related (ATTR) amyloidosis | Can lead a claim | I | None |
| E85.89 | Other amyloidosis | Can lead a claim | I | None |
| E85.9 | Amyloidosis, unspecified | Can lead a claim | I | None |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue